Variable | Resultsa (no stroke) (N = 257) | Resultsa (stroke) (N = 96) | p-value | adjusted Odds Ratio | CI (95%) |
---|---|---|---|---|---|
Left heart affected (mitral and/or aortic valve) | 212 (82.5%) | 95 (99.0%) | 0.001 | 28.26 | 3.59-222.19 |
Extracerebral arterial embolic events | 42 (16.3%) | 36 (37.5%) | 0.004 | 2.52 | 1.33–4.71 |
Acute liver failure | 19 (7.4%) | 19 (19.8%) | 0.037 | 2.62 | 1.06–6.50 |
Dental focus of infection | 17 (6.6%) | 12 (12.5%) | 0.019 | 3.12 | 1.21–8.12 |
Intracardiac medical devices other than artificial heart valves (e.g. MitraClip, ICD, pacemaker) | 63 (24.5%) | 11 (11.5%) | 0.055 | 0.46 | 0.21–1.02 |
Congenital heart disease (e.g. bicuspid aortic valve) | 26 (10.1%) | 2 (2.1%) | 0.049 | 0.20 | 0.04–0.99 |
Previous heart disease other than congenital heart disease | 88 (34.2%) | 23 (24.0%) | 0.139 | 0.62 | 0.33–1.17 |
Acute renal failure requiring HD | 49 (19.1%) | 27 (28.1%) | 0.949 | 0.98 | 0.49–1.96 |
Pathogen isolated in blood culture (no pathogen found = ref) | |||||
Staphylococcus aureus | 56 (21.8%) | 35 (36.5%) | 0.876 | 0.94 | 0.41–2.15 |
Staphylococcus epidermidis | 31 (12.1%) | 6 (6.3%) | 0.051 | 0.32 | 0.10-1.00 |
Streptococcus mitis/oralis | 19 (7.4%) | 5 (5.2%) | 0.137 | 0.36 | 0.10–1.38 |
Enterococcus faecalis | 27 (10.5%) | 10 (10.4%) | 0.610 | 0.77 | 0.28–2.14 |
Other | 97 (37.7%) | 21 (21.9%) | 0.006 | 0.31 | 0.14–0.72 |